Combination Of Cd160 And Cd200 As A Useful Tool For Differential Diagnosis Between Chronic Lymphocytic Leukemia And Other Mature B-Cell Neoplasms
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY(2015)
Abstract
IntroductionChronic lymphocytic leukemia is usually diagnosed through the characteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in diagnostic uncertainty.MethodsUsing flow cytometry analysis, we investigated the expression of CDs160/200 on B cells from 124 patients (82 CLL, 42 other B-cell neoplasms) and nine controls. CDs160/200 measurements were determined as a ratio of the mean fluorescence intensities of leukemic cells/controls and were considered positive when the ratios were 2 and 20, respectively.ResultsSixty and 83% CLL expressed CDs160/200 as compared to 5% and 10% of other B-cell neoplasms, respectively. None of the controls showed CDs160/200 expressions. Combination of both markers was observed in 55% of CLL but only in 2% of other B-cell neoplasms, and absence of both markers occurred in 12% of CLL but in 86% of other B-cell neoplasms.ConclusionCDs160/200 were associated with markers of the gold standard Matutes score' and could be useful markers to differentiate atypical CLL from other B-cell neoplasms in the absence of available biopsies or cytogenetics and molecular studies.
MoreTranslated text
Key words
CLL,CD160,CD200,B-cell neoplasms,immunophenotyping
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined